SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.
Modified vaccinia virus Ankara (MVA) is the leading poxvirus vector for development of vaccines against diverse infectious diseases. This distinction is based on high expression of proteins and good immunogenicity despite an inability to assemble infectious progeny in human cells, which together pro...
Main Authors: | Ruikang Liu, Jorge D Mendez-Rios, Chen Peng, Wei Xiao, Andrea S Weisberg, Linda S Wyatt, Bernard Moss |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-05-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1007710 |
Similar Items
-
Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells.
by: Chen Peng, et al.
Published: (2020-08-01) -
A Genotype of Modified Vaccinia Ankara (MVA) that Facilitates Replication in Suspension Cultures in Chemically Defined Medium
by: Volker Sandig, et al.
Published: (2013-01-01) -
Diseño y construcción de vectores de transferencia para la obtención de virus vaccinia Ankara modificado (MVA) recombinantes Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)
by: M. F. Ferrer, et al.
Published: (2007-09-01) -
Untersuchung von Modifiziertem Vaccinia Ankara Virus (MVA) zur Induktion Cytomegalovirus (CMV) spezifischer T-Zell-Antworten
by: Flechsig, Christin
Published: (2011) -
Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
by: Matthew G Cottingham, et al.
Published: (2008-02-01)